Senolytics are a class of drugs that selectively clear senescent cells, which can help to reverse aging and keep you feeling ...

Senolytics—a class of drugs that reduce chronic inflammation and tissue damage in aging cells—are shown to eliminate 30% to 70% of "zombie" cells in the body. These zombie cells, known as senescent ...

Senescent cells are somewhat of a boogeyman lately, blamed for many of the unpleasant effects of aging. As such, they’re targeted by an increasing range of anti-aging therapies – but we might not want ...

In a recent study published in the journal Nature Aging, an international team of researchers observed that senolytics can alleviate physiologic brain aging and coronavirus disease 2019 (COVID-19) ...

A new pilot study known as STAMINA (Senolytics To Alleviate Mobility Issues and Neurological Impairments in Aging), that focused on the effects of senolytic medications, Dasatinib and Quercetin (DQ), ...

Cellular senescence refers to a state of irreversible arrest of cell proliferation. It was first described by Hayflick and colleagues in the 1960s when they observed cessation of cell proliferation ...

Senolytics are an emerging class of drugs designed to target zombie-like cells that have stopped dividing and build up in the body as we age, and the past few years have seen some exciting discoveries ...

In a sterile laboratory, researchers examine petri dishes containing what could be the key to extending human lifespan. These aren’t experimental stem cells or gene therapies, but rather compounds ...

“This work provides new opportunities for the development of the next generation of ChE inhibitors that specifically target AChE and BChE associated with AD pathology.” “This work provides new ...

SOMERSET, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Cepham, a leader in Ayurvedic nutraceuticals research and sustainable self-care solutions, has announced the expansion of its Sustainable Aging ...

NEW YORK--(BUSINESS WIRE)--Bonerge announced the initiation of its clinical trial, focusing on Fisetin, Urolithin A, and Ergothioneine. Involving 108 participants, this trial aims to evaluate their ...